Exhibit 107


Calculation of Filing Fee Table



(Form Type)


PharmaCyte Biotech, Inc.

(Exact Name of Registrant as Specified in its Charter)


Table 1 – Transaction Valuation









Amount of

Filing Fee

Fees to Be Paid    $25,187,500.00(1)     0.00011020     $2,775.66(2) 
Fees Previously Paid      
Total Transaction Valuation    $25,187,500.00(1)         
Total Fees Due for Filing           $2,775.66
Total Fees Previously Paid          
Total Fee Offsets          
Net Fee Due           $2,775.66



(1) The transaction valuation is estimated only for purposes of calculating the filing fee. This amount is based on the purchase of 7,750,000 shares of common stock, par value $0.0001 per share, at the tender offer price of $3.25 per share.


(2) The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $110.20 per $1,000,000 of the aggregate amount of the Transaction Valuation (or 0.01102% of the aggregate Transaction Valuation). The Transaction Valuation set forth above was calculated for the sole purpose of determining the filing fee and should not be used for any other purpose.